An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)
Clinical trial NCT03198130 · COMPLETED
Trial details
- NCT number
- NCT03198130
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-03
- Primary completion
- 2019-06-27
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.